Cargando…
PB2125: LYMPHOMATOID PAPULOSIS-LIKE (LYP-LIKE) AFTER BRENTUXIMAB VEDOTIN-CHP (BV-CHP) TREATMENT FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429098/ http://dx.doi.org/10.1097/01.HS9.0000851332.62295.97 |
| _version_ | 1784779328849969152 |
|---|---|
| author | Lopez Pereira, P. Servitje, O. Climent, F. Domingo-Domenech, E. Oliveira, A. Muniesa, C. Sureda, A. González-Barca, E. |
| author_facet | Lopez Pereira, P. Servitje, O. Climent, F. Domingo-Domenech, E. Oliveira, A. Muniesa, C. Sureda, A. González-Barca, E. |
| author_sort | Lopez Pereira, P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429098 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94290982022-08-31 PB2125: LYMPHOMATOID PAPULOSIS-LIKE (LYP-LIKE) AFTER BRENTUXIMAB VEDOTIN-CHP (BV-CHP) TREATMENT FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) Lopez Pereira, P. Servitje, O. Climent, F. Domingo-Domenech, E. Oliveira, A. Muniesa, C. Sureda, A. González-Barca, E. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429098/ http://dx.doi.org/10.1097/01.HS9.0000851332.62295.97 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Lopez Pereira, P. Servitje, O. Climent, F. Domingo-Domenech, E. Oliveira, A. Muniesa, C. Sureda, A. González-Barca, E. PB2125: LYMPHOMATOID PAPULOSIS-LIKE (LYP-LIKE) AFTER BRENTUXIMAB VEDOTIN-CHP (BV-CHP) TREATMENT FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) |
| title | PB2125: LYMPHOMATOID PAPULOSIS-LIKE (LYP-LIKE) AFTER BRENTUXIMAB VEDOTIN-CHP (BV-CHP) TREATMENT FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) |
| title_full | PB2125: LYMPHOMATOID PAPULOSIS-LIKE (LYP-LIKE) AFTER BRENTUXIMAB VEDOTIN-CHP (BV-CHP) TREATMENT FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) |
| title_fullStr | PB2125: LYMPHOMATOID PAPULOSIS-LIKE (LYP-LIKE) AFTER BRENTUXIMAB VEDOTIN-CHP (BV-CHP) TREATMENT FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) |
| title_full_unstemmed | PB2125: LYMPHOMATOID PAPULOSIS-LIKE (LYP-LIKE) AFTER BRENTUXIMAB VEDOTIN-CHP (BV-CHP) TREATMENT FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) |
| title_short | PB2125: LYMPHOMATOID PAPULOSIS-LIKE (LYP-LIKE) AFTER BRENTUXIMAB VEDOTIN-CHP (BV-CHP) TREATMENT FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) |
| title_sort | pb2125: lymphomatoid papulosis-like (lyp-like) after brentuximab vedotin-chp (bv-chp) treatment for alk-negative anaplastic large cell lymphoma (alcl) |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429098/ http://dx.doi.org/10.1097/01.HS9.0000851332.62295.97 |
| work_keys_str_mv | AT lopezpereirap pb2125lymphomatoidpapulosislikelyplikeafterbrentuximabvedotinchpbvchptreatmentforalknegativeanaplasticlargecelllymphomaalcl AT servitjeo pb2125lymphomatoidpapulosislikelyplikeafterbrentuximabvedotinchpbvchptreatmentforalknegativeanaplasticlargecelllymphomaalcl AT climentf pb2125lymphomatoidpapulosislikelyplikeafterbrentuximabvedotinchpbvchptreatmentforalknegativeanaplasticlargecelllymphomaalcl AT domingodomeneche pb2125lymphomatoidpapulosislikelyplikeafterbrentuximabvedotinchpbvchptreatmentforalknegativeanaplasticlargecelllymphomaalcl AT oliveiraa pb2125lymphomatoidpapulosislikelyplikeafterbrentuximabvedotinchpbvchptreatmentforalknegativeanaplasticlargecelllymphomaalcl AT muniesac pb2125lymphomatoidpapulosislikelyplikeafterbrentuximabvedotinchpbvchptreatmentforalknegativeanaplasticlargecelllymphomaalcl AT suredaa pb2125lymphomatoidpapulosislikelyplikeafterbrentuximabvedotinchpbvchptreatmentforalknegativeanaplasticlargecelllymphomaalcl AT gonzalezbarcae pb2125lymphomatoidpapulosislikelyplikeafterbrentuximabvedotinchpbvchptreatmentforalknegativeanaplasticlargecelllymphomaalcl |